MEDRAD MR Infusion System FDA Cleared for 3.0T
Indianola, PA - MEDRAD received Food and Drug Administration (FDA) clearance for use of its Continuum MR Infusion System in magnetic resonance (MR) environments up to and including 3.0 Tesla (T). The new FDA clearance enables clinicians working in the latest 3.0T environments to infuse medications, sedatives, and other drugs while benefiting from Continuum's ease-of-use and dose enhancements.
"MEDRAD created the category for MR compatible infusion systems with the Continuum MR Infusion System," said Gary Bucciarelli, senior vice president, Magnetic Resonance Business Unit. "Innovation has been a hallmark of Continuum and the clearance for 3.0T helps us reach new patients with this advanced technology."
To learn more about Continuum use for 3.0T environments, customers and current Continuum users can contact their MEDRAD representative for information and to arrange to receive the upgrade kit.
Continuum was introduced in 2002 as the first MR compatible infusion system, meeting the need for safe and reliable infusion during MRI procedures in strengths up to 1.5T, the market standard at the time. With the advent of higher strength magnets, MEDRAD began extensive testing in 3.0T, and Continuum is now cleared to provide guidance for safety and performance in that environment. MR accessory equipment must meet safety standards and perform without interfering with the quality of medical images. Tests for attraction, homogeneity, artifact, and static magnetic field are designed to ensure that Continuum meets or exceeds these requirements, and the results confirm that it does.
In the most recent enhancement to Continuum, MEDRAD added a greater selection of drug-specific units of measurement, increasing the number of drugs that can be infused. It also helps prevent programming errors by reducing the confusion of manual conversions.
For over a decade, MEDRAD has delivered advanced technology to the MR suite and supported it with a robust global support organization. Other MEDRAD MR products include the Spectris Solaris EP Injection System and a wide array of Leading Image Coils, as well as the VerisTM MR Patient Monitor, winner of the Frost & Sullivan Customer Value Enhancement Award in 2005.
SOURCE: MEDRAD, INC.